| Efflux-Pump—Derived Multiple Drug Resistance to Ethambutol Monotherapy in Mycobacterium tuberculosis and the Pharmacokinetics and Pharmacodynamics of … S Srivastava, S Musuka, C Sherman, C Meek, R Leff, T Gumbo The Journal of infectious diseases 201 (8), 1225-1231, 2010 | 153 | 2010 |
| Linezolid dose that maximizes sterilizing effect while minimizing toxicity and resistance emergence for tuberculosis S Srivastava, G Magombedze, T Koeuth, C Sherman, JG Pasipanodya, ... Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00751-17, 2017 | 102 | 2017 |
| Mechanisms of cellular resistance to hydrogen peroxide, hyperoxia, and 4-hydroxy-2-nonenal toxicity: the significance of increased catalase activity in H2O2-resistant fibroblasts DR Spitz, DT Adams, CM Sherman, RJ Roberts Archives of biochemistry and biophysics 292 (1), 221-227, 1992 | 101 | 1992 |
| Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: The significance of increased catalase activity and total glutathione in hydrogen peroxide … DR Spitz, JW Phillips, DT Adams, CM Sherman, DF Deen, GC Li Journal of cellular physiology 156 (1), 72-79, 1993 | 79 | 1993 |
| Pharmacokinetic mismatch does not lead to emergence of isoniazid-or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for … S Srivastava, C Sherman, C Meek, R Leff, T Gumbo Antimicrobial agents and chemotherapy 55 (11), 5085-5089, 2011 | 51 | 2011 |
| A long-term co-perfused disseminated tuberculosis-3D liver hollow fiber model for both drug efficacy and hepatotoxicity in babies S Srivastava, JG Pasipanodya, G Ramachandran, D Deshpande, ... EBioMedicine 6, 126-138, 2016 | 48 | 2016 |
| Amikacin pharmacokinetics/pharmacodynamics in a novel hollow-fiber Mycobacterium abscessus disease model BE Ferro, S Srivastava, D Deshpande, CM Sherman, JG Pasipanodya, ... Antimicrobial agents and chemotherapy 60 (3), 1242-1248, 2016 | 43 | 2016 |
| Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii disease S Srivastava, J Pasipanodya, CM Sherman, C Meek, R Leff, T Gumbo Antimicrobial agents and chemotherapy 59 (4), 2273-2279, 2015 | 23 | 2015 |
| A ‘shock and awe’ thioridazine and moxifloxacin combination-based regimen for pulmonary Mycobacterium avium–intracellulare complex disease S Srivastava, D Deshpande, CM Sherman, T Gumbo Journal of Antimicrobial Chemotherapy 72 (suppl_2), i43-i47, 2017 | 16 | 2017 |
| Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration T Gumbo, CM Sherman, D Deshpande, JW Alffenaar, S Srivastava International Journal of Infectious Diseases 104, 680-684, 2021 | 10 | 2021 |
| A new Aleiodes (= Tetrasphaeropyx)(= A. pilosus group), with a host record from Missouri, USA, biological remarks, and previous type depository corrections J Fortier, C Sherman Entomological News 119 (5), 445-453, 2008 | 3 | 2008 |
| In vitro susceptibility testing and totally drug-resistant tuberculosis S Srivastava, C Sherman, T Gumbo European Respiratory Journal 42 (1), 291-292, 2013 | 2 | 2013 |
| Mechanisms of resistance to oxidative stress in O2-resistant cells DR Spitz, SJ Sullivan, MT Kinter, DT Adams, CM Sherman, RJ Roberts Free Radical Biology and Medicine 15 (5), 517, 1993 | 1 | 1993 |
| THE EFFECT OF GLUTATHIONE DEPLETION ON RESISTANCE TO O2-TOXICITY AND ACCUMULATION OF PROTEIN-BOUND 4-HYDROXY-2-NONENAL IN CELLS DR Spitz, MT Kinter, DT Adams, S Rodig, CM Sherman, RJ Roberts PEDIATRIC RESEARCH 29 (4), A66-A66, 1991 | 1 | 1991 |
| Linezolid dose that maximizes sterilizing effect while minimizing toxicity and resistance emergence for tuberculosis. SS Shashikant Srivastava, G Magombedze, T Koeuth, C Sherman, ... | | 2017 |
| THE EFFECT OF UNSATURATED FATTY-ACIDS, LINOLEIC OR EICOSAPENTAENOIC ACID, ON O2-TOXICITY IN CULTURED-CELLS DR SPITZ, MT KINTER, JP KEHRER, DT ADAMS, CM SHERMAN, ... PEDIATRIC RESEARCH 29 (4), A331-A331, 1991 | | 1991 |
| CYTOTOXICITY AND METABOLISM OF 4-HYDROXY-2-NONENAL IN AN O2-RESISTANT CELL-LINE SJ SULLIVAN, DT ADAMS, CM SHERMAN, RJ ROBERTS, DR SPITZ PEDIATRIC RESEARCH 29 (4), A52-A52, 1991 | | 1991 |
| Cytotoxicity and metabolism of 4-hydroxy-2-nonenal in O2-resistant cell lines SJ Sullivan, RJ Roberts, DT Adams, CM Sherman, DR Spitz Free Radical Biology and Medicine 9, 111, 1990 | | 1990 |
